C4 Therapeutics (CCCC) Return on Equity [ROE] (2020 - 2026)
C4 Therapeutics (CCCC) reported Return on Equity [ROE] of -42.07% for Q2 2026, up 18.37 percentage points from -60.44% a year earlier and up 0.17 percentage points from the prior quarter.
Powered by 
Analysis
C4 Therapeutics (CCCC) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, C4 Therapeutics posted Return on Equity [ROE] of -44.44%, up 1.15 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +34.15 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -45.58% in FY2024 (+3.92 pp), -49.50% in FY2023 (-11.73 pp), -37.76% in FY2022 (-12.74 pp) and -25.03% in FY2021 (+53.56 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q4 2022.
- Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of +0.27 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 84.97 percentage points); the low point was Q3 2025 (a drop of 29.42 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -42.25% (Q1 2026), -51.03% (Q4 2025) and -72.51% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | C4 Therapeutics | 393.93 Mn | -549.34 Mn | - | -38.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -38.80% |
| Jun 30, 2026 | -42.30% |
| Mar 31, 2026 | -42.44% |
| Dec 31, 2025 | -51.09% |
| Sep 30, 2025 | -72.73% |
| Jun 30, 2025 | -60.22% |
| Mar 31, 2025 | -50.04% |
| Dec 31, 2024 | -45.85% |
| Sep 30, 2024 | -42.53% |
| Jun 30, 2024 | -42.16% |
| Mar 31, 2024 | -49.16% |
| Dec 31, 2023 | -55.60% |
| Sep 30, 2023 | -58.00% |
| Jun 30, 2023 | -55.24% |
| Mar 31, 2023 | -47.18% |
| Dec 31, 2022 | -43.31% |
| Sep 30, 2022 | -33.77% |
| Jun 30, 2022 | -29.30% |
| Mar 31, 2022 | -26.02% |
| Dec 31, 2021 | -21.48% |
API Access
C4 Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CCCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();